These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1111 related articles for article (PubMed ID: 30194957)

  • 1. α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.
    Cooper JF; Spielbauer KK; Senchuk MM; Nadarajan S; Colaiácovo MP; Van Raamsdonk JM
    Exp Neurol; 2018 Dec; 310():58-69. PubMed ID: 30194957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of α-synuclein in C. elegans.
    Bornhorst J; Chakraborty S; Meyer S; Lohren H; Brinkhaus SG; Knight AL; Caldwell KA; Caldwell GA; Karst U; Schwerdtle T; Bowman A; Aschner M
    Metallomics; 2014 Mar; 6(3):476-90. PubMed ID: 24452053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring Caenorhabditis elegans as Parkinson's Disease Model: Neurotoxins and Genetic Implications.
    da Silva LPD; da Cruz Guedes E; Fernandes ICO; Pedroza LAL; da Silva Pereira GJ; Gubert P
    Neurotox Res; 2024 Feb; 42(1):11. PubMed ID: 38319410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling Parkinson's Disease in C. elegans.
    Cooper JF; Van Raamsdonk JM
    J Parkinsons Dis; 2018; 8(1):17-32. PubMed ID: 29480229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Caenorhabditis elegans Parkin mutant with altered solubility couples alpha-synuclein aggregation to proteotoxic stress.
    Springer W; Hoppe T; Schmidt E; Baumeister R
    Hum Mol Genet; 2005 Nov; 14(22):3407-23. PubMed ID: 16204351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
    Yasuda T; Mochizuki H
    Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maackiain Ameliorates 6-Hydroxydopamine and
    Tsai RT; Tsai CW; Liu SP; Gao JX; Kuo YH; Chao PM; Hung HS; Shyu WC; Lin SZ; Fu RH
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32585871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson's disease genes.
    Berkowitz LA; Hamamichi S; Knight AL; Harrington AJ; Caldwell GA; Caldwell KA
    J Vis Exp; 2008 Jul; (17):. PubMed ID: 19066512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osmotic stress induced toxicity exacerbates Parkinson's associated effects via dysregulation of autophagy in transgenic C. elegans model.
    Jadiya P; Mir SS; Nazir A
    Cell Signal; 2018 May; 45():71-80. PubMed ID: 29410282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulated Interorganellar Crosstalk of Mitochondria in the Pathogenesis of Parkinson's Disease.
    Sironi L; Restelli LM; Tolnay M; Neutzner A; Frank S
    Cells; 2020 Jan; 9(1):. PubMed ID: 31963435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alpha-synuclein in Parkinson's disease].
    Oczkowska A; Kozubski W; Dorszewska J
    Przegl Lek; 2014; 71(1):26-32. PubMed ID: 24712265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodegeneration in Parkinson's disease: genetics enlightens physiopathology.
    Corti O; Fournier M; Brice A
    J Neural Transm Suppl; 2009; (73):215-21. PubMed ID: 20411780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Animal models for familial Parkinson's disease].
    Takahashi R
    Rinsho Shinkeigaku; 2007 Nov; 47(11):938-40. PubMed ID: 18210841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease?
    Volpicelli-Daley LA; Kirik D; Stoyka LE; Standaert DG; Harms AS
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl 1):131-155. PubMed ID: 27018978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkin counteracts symptoms in a Drosophila model of Parkinson's disease.
    Haywood AF; Staveley BE
    BMC Neurosci; 2004 Apr; 5():14. PubMed ID: 15090075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Developments in Genetic rat models of Parkinson's Disease.
    Creed RB; Goldberg MS
    Mov Disord; 2018 May; 33(5):717-729. PubMed ID: 29418019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
    Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
    Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson's Disease Models In Vivo and In Vitro.
    Hsu YL; Hung HS; Tsai CW; Liu SP; Chiang YT; Kuo YH; Shyu WC; Lin SZ; Fu RH
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
    Sharma N; Rao SP; Kalivendi SV
    Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.